SLEEP, vol. 22, n° 6, 1999, pages 749-755, 15 réf., ISSN 0161-8105, USA
KAPUR (V.), BLOUGH (D.K.), SANDBLOM (R.E.), HERT (R.), DE MAINE (J.B.), SULLIVAN (S.D.), PSATY (B.M.)
Pulmonary Division. Group Health Cooperative of Puget Sound. USA
Obstructive sleep apnea is an under-diagnosed, but common disorder with serious adverse consequences.
Cost data from the year prior to the diagnosis of sleep-disordered breathing in a consecutive series of 238 cases were used to estimate the potential medical cost of undiagnosed sleep apnea and to determine the relationship between the severity of sleep-disordered breathing and the magnitude of medical costs.
Among cases, mean annual medical cost prior to diagnosis was $2720 versus $1384 for age and gender matched controls (p<0.01).
Regression analysis showed that the reciprocal of the apnea hypopnea index among cases was significantly related to log-transformed annual medical costs after adjusting for age, gender, and body mass index (p<0.05).
We conclude that patients with undiagnosed sleep apnea had considerably higher medical costs than age and sex matched individuals and that the severity of sleep-disordered breathing was associated with the magnitude of medical costs.
Using available data on the prevalence of undiagnosed moderate to severe sleep apnea in middle-aged adults, we estimate that untreated sleep apnea may cause $3.4 billion in additional medical costs in the U.S. Whether medical cost savings occur with treatment of sleep apnea remains to be determined.
Mots-clés BDSP : Coût, Diagnostic, Trouble sommeil, Homme
Mots-clés Pascal : Apnée sommeil syndrome, Obstruction, Voie respiratoire supérieure, Coût, Service santé, Diagnostic, Trouble sommeil, Homme
Mots-clés Pascal anglais : Sleep apnea syndrome, Obstruction, Upper respiratory tract, Costs, Health service, Diagnosis, Sleep disorder, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0454676
Code Inist : 002B10B02. Création : 22/03/2000.